While mainstream media ramps up another wave of COVID fearmongering, demand for mRNA gene therapies continues to nosedive (despite warnings of a new hybrid mutant strain). Moderna shares started tanking on Tuesday after two strategic global supranational bodies representing low- and middle-income countries rejected the purchase hundreds of millions of additional doses of the company’s … Continue reading African Union & Covax Reject Hundreds of Millions of Additional Moderna COVID-19 Jab Doses